Acquire the license to the best health content in the world
Contact Us

Physician's Briefing Weekly Coronavirus Roundup

Weekly Coronavirus Roundup
Adobe Stock

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 1 to 5, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent

FRIDAY, Nov. 5, 2021 (HealthDay News) -- Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89 percent in infected high-risk people.

Read Full Text

New U.S. COVID-19 Vaccinations Climb for the Longest Stretch in Months

FRIDAY, Nov. 5, 2021 (HealthDay News) -- The number of new COVID-19 vaccinations in the United States rose for eight straight days in late October, the longest period of increases since early August, government data show.

Read Full Text

Insulin Rx Fills Down During the Pandemic

FRIDAY, Nov. 5, 2021 (HealthDay News) -- There has been a considerable decrease in the average number of weekly insulin prescription fills during the COVID-19 pandemic, according to a research letter published online Nov. 3 in JAMA Network Open.

Read Full Text

Heart Attack + COVID-19 Significantly Ups In-Hospital Mortality

FRIDAY, Nov. 5, 2021 (HealthDay News) -- Among patients with ST-segment elevation myocardial infarction, a concomitant diagnosis of COVID-19 is associated with significantly higher rates of in-hospital mortality, according to a study published online Oct. 29 in the Journal of the American Medical Association.

Read Full Text

More Than 28 Million Excess Years of Life Lost in 2020

FRIDAY, Nov. 5, 2021 (HealthDay News) -- In 31 countries, there were more than 28 million excess years of life lost in 2020, according to a study published online Nov. 3 in The BMJ.

Read Full Text

Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes

FRIDAY, Nov. 5, 2021 (HealthDay News) -- Receipt of a third dose of the BNT162b2 mRNA vaccine appears to be effective for reducing severe COVID-19 outcomes compared with receipt of two doses at least five months ago, according to a study published online Oct. 29 in The Lancet.

Read Full Text

More Teen Screen Time During Pandemic Tied to Worse Mental Health, Stress

FRIDAY, Nov. 5, 2021 (HealthDay News) -- Early in the pandemic, adolescents reported spending nearly eight hours a day on screens, according to a research letter published online Nov. 1 in JAMA Pediatrics.

Read Full Text

White House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate Vaccines

THURSDAY, Nov. 4, 2021 (HealthDay News) -- Large U.S. companies have until Jan. 4, 2022, to ensure their employees are fully vaccinated against COVID-19, the Biden administration said Thursday.

Read Full Text

COVID-19 Widespread Among Iowa Deer

THURSDAY, Nov. 4, 2021 (HealthDay News) -- The discovery that up to 80 percent of white-tailed deer in Iowa may be infected with COVID-19 has scientists worried that the animals could become a reservoir for variants that could come back to haunt humans.

Read Full Text

mRNA COVID-19 Efficacy Lower for Immunocompromised Adults

THURSDAY, Nov. 4, 2021 (HealthDay News) -- Vaccine effectiveness of two doses of mRNA COVID-19 vaccine against COVID-19-associated hospitalization is lower among immunocompromised adults, according to research published in the Nov. 2 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Read Full Text

Allergy History May Up Risk for Reactions to mRNA COVID-19 Vaccine

THURSDAY, Nov. 4, 2021 (HealthDay News) -- Self-reported history of high-risk allergy is associated with an increased risk for self-reported allergic reactions within three days of mRNA COVID-19 vaccination among health care workers, according to a study published online Oct. 26 in JAMA Network Open.

Read Full Text

Liver Transplants for Alcoholic Hepatitis Up During COVID-19 Pandemic

WEDNESDAY, Nov. 3, 2021 (HealthDay News) -- Waiting-list registrations and liver transplants for alcoholic hepatitis have increased, exceeding the forecasted volumes, in association with increasing retail alcohol sales during the COVID-19 pandemic, according to a study published online Oct. 26 in JAMA Network Open.

Read Full Text

Psychologists Find Demand for Mental Health Services Still Rising

WEDNESDAY, Nov. 3, 2021 (HealthDay News) -- Psychologists are reporting a large increase in demand for treatment of anxiety and depression in 2021, according to a survey released by the American Psychological Association.

Read Full Text

CDC Panel Signs Off on Pfizer Vaccine for Younger Children

TUESDAY, Nov. 2, 2021 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention vaccine advisory panel voted unanimously on Tuesday to recommend emergency use of the Pfizer COVID-19 vaccine in children ages 5 to 11 years.

Read Full Text

'Delta Plus' Variant Surfaces in Eight U.S. States

TUESDAY, Nov. 2, 2021 (HealthDay News) -- U.S. health officials say they are keeping close watch on a "delta plus" variant that has been detected in at least eight states.

Read Full Text

EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine

TUESDAY, Nov. 2, 2021 (HealthDay News) – The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Nov. 2 in JAMA Network Open.

Read Full Text

Postacute COVID-19 Syndrome May Affect Physical, Cognitive Function

TUESDAY, Nov. 2, 2021 (HealthDay News) -- Persistent symptoms associated with postacute COVID-19 syndrome may impact physical and cognitive function as well as quality of life, according to a study published online Oct. 20 in the American Journal of Physical Medicine & Rehabilitation.

Read Full Text

ACS: Bicycle-Related Injuries, Gunshot Wounds Up During Pandemic

TUESDAY, Nov. 2, 2021 (HealthDay News) -- During the course of the pandemic, the number of trauma cases involving bicycle-related injuries and gunshot wounds has risen substantially, according to a study presented at the annual meeting of the American College of Surgeons, held virtually from Oct. 23 to 27.

Read Full Text

FDA Delays Decision on Moderna COVID-19 Vaccine for Younger Teens

MONDAY, Nov. 1, 2021 (HealthDay News) -- The U.S. Food and Drug Administration has delayed a decision on whether to approve emergency use of the Moderna COVID-19 vaccine in 12- to 17-year-olds until at least January, the company announced Sunday.

Read Full Text

Vaccinations for Children Will Be in Full Swing by Nov. 8, White House Says

MONDAY, Nov. 1, 2021 (HealthDay News) -- The U.S. government's COVID-19 vaccination program for children ages 5 to 11 years will be ready to roll on Nov. 8, the White House said Monday.

Read Full Text

COVID-19 Death Toll Tops 5 Million Worldwide

MONDAY, Nov. 1, 2021 (HealthDay News) -- The worldwide death toll from COVID-19 surpassed 5 million on Monday, and the more than 740,000 lives lost in the United States is the most of any nation, Johns Hopkins University data show.

Read Full Text

COVID-19 Vaccine-Induced Immunity More Protective Than Infection

MONDAY, Nov. 1, 2021 (HealthDay News) – The odds of COVID-19 hospitalization are increased more than fivefold for unvaccinated patients with a previous severe acute respiratory syndrome coronavirus 2 infection than among individuals who are fully vaccinated with an mRNA COVID-19 vaccine, according to research published in the Oct. 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Read Full Text

Fully Vaccinated With Breakthrough Infection Can Transmit COVID-19

MONDAY, Nov. 1, 2021 (HealthDay News) -- Fully vaccinated individuals with breakthrough COVID-19 infection have a viral load similar to unvaccinated cases and can transmit infection in a household setting, according to a study published online Oct. 28 in The Lancet Infectious Diseases.

Read Full Text

Cerebral Venous Sinus Thrombosis Rate Up After Ad26.COV2.S Shot

MONDAY, Nov. 1, 2021 (HealthDay News) -- The cerebral venous sinus thrombosis rate is increased after Ad26.COV2.S vaccination compared with the prepandemic rate, according to a research letter published online Nov. 1 in JAMA Internal Medicine.

Read Full Text

Pediatric Critical Care Professionals Experiencing Moral Distress

MONDAY, Nov. 1, 2021 (HealthDay News) -- Pediatric critical care professionals are experiencing moral distress during the COVID-19 pandemic, but they have also shown attributes of moral resilience, according to a study published online Nov. 1 in the American Journal of Critical Care.

Read Full Text

Physician's Briefing